- Home
- KRYS vs EMN Comparison
KRYS vs EMN Comparison
Compare KRYS & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRYS | EMN |
|---|---|---|
| Founded | 2015 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.3B |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KRYS | EMN |
|---|---|---|
| Price | $347.00 | $68.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $297.60 | $79.31 |
| AVG Volume (30 Days) | 200.3K | ★ 781.6K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.77% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 3.62 | 2.51 |
| Revenue | $389,130,000.00 | ★ $8,752,000,000.00 |
| Revenue This Year | $38.74 | $3.06 |
| Revenue Next Year | $32.53 | $3.47 |
| P/E Ratio | $96.16 | ★ $27.23 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $145.46 | $56.11 |
| 52 Week High | $382.54 | $83.47 |
Technical Indicators
Market Signals| Indicator | KRYS | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 37.45 |
| Support Level | $289.36 | $66.37 |
| Resistance Level | $382.33 | $70.42 |
| Average True Range (ATR) | 11.24 | 1.76 |
| MACD | -0.73 | -0.62 |
| Stochastic Oscillator | 28.36 | 8.30 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.